CANCERCOREEUROPE CONFERENCE ON LYMPHOMA 2016 filejanuary 22nd, 2016 cancercoreeurope conference on...
Transcript of CANCERCOREEUROPE CONFERENCE ON LYMPHOMA 2016 filejanuary 22nd, 2016 cancercoreeurope conference on...
JANUARY 22nd, 2016
CANCERCOREEUROPE CONFERENCE ON
LYMPHOMA 2016HEIDELBERG - GERMANYGERMAN CANCER RESEARCH CENTER (DKFZ), Lecture Hall
08:30 Registration
09:30 Welcome Fabien Calvo, Anthony Ho, Christof von Kalle und Thorsten Zenz
Session I: Indolent Lymphoma Chairs: Hedda Wardemann / Vincent Ribrag
09:45 Molecular Basis of Indolent Lymphoma Ingo Ringshausen, Cambridge
10:10 Standard of Care 2016 Martin Dreyling, München
10:35 Future Directions Improving Outcome in Indolent Lymphoma Vincent Ribrag, Paris
11:00 Clinical Implications of Gene Mutations in Follicular Lymphoma (Abstract) Oliver Weigert, München
11:15 Coffee Break
Session II: CLL Chairs: Francesc Bosch / Anders Österborg
11:30 Molecular Basis of CLL Olivier Bernard, Paris
11:55 Standard of Care 2016 Francesc Bosch, Barcelona
12:20 Future Directions Improving Outcome in CLL Anders Österborg, Stockholm
13:00 Lunch
Session III: Aggressive B-NHL Chairs: George Follows / Thorsten Zenz
14:00 Molecular Basis of Aggressive B-NHL Clemens Schmitt, Berlin
14:25 Standard of Care 2016 Christian Gisselbrecht, Paris
14:50 Future Directions Improving Outcome in Aggressive B-NHL Georg Lenz, Münster
15:15 FOXO1 Impacts on Germinal Center Derived Lymphomagenesis (Abstract) Sandrine Sander, Heidelberg
Session IV: T-NHL Chairs: Hans-Reimer Rodewald / Mathias Witzens-Harig
15:45 Molecular Basis of T-NHL Laurence de Leval, Lausanne
16:10 Standard of Care 2016 Lorenz Trümper, Göttingen
16:35 Future Directions Improving Outcome in T-NHL Pier Luigi Zinzani, Bologna
17:00 The Pan-PIM Kinase Inhibitor LGB321 Targets Apoptotic Pathways and Microenvironmental Interactions in CLL (Abstract) Christine Dierks, Freiburg
17:15 Coffee Break
17:45 Satellite Symposium Chairs: Susan O’Brien / Christian Peschel
17:45 Improving Chemotherapy in NHL Kieron Dunleavy, Bethesda
18:10 BCR Inhibition in B-Cell Lymphoma/CLL Susan O’Brien, Irvine
18:35 Strategies for Cure in CLL Michael Hallek, Cologne
19:00 Drug Sensitivity-Based Functional Taxonomy of Lymphoma Thorsten Zenz, Heidelberg
20:00 Get-Together
Registration:
Fortbildungs- und Veranstaltungsorganisation des Nationalen Centrums für Tumorerkrankungen (NCT) Heidelberg School of Oncology
Im Neuenheimer Feld 460 69120 Heidelberg Phone +49 (0) 6221 56-6558 viktoria.reinhardt@ nct-heidelberg.de www.nct-heidelberg.de/ lymphoma2016
For this event, six points for continuing education will be given by the „Landesärzte kammer“
WITH FRIENDLY SUPPORT OF (PROMOTION AND PRESENTATION):
(1.000,00€)
(5.000,00€)Erste Wahl für das zwei te Leben
(5.000,00€)
(10.000,00€)
(10.000,00€)
(10.000,00€)
(3.000,00€)
(3.000,00€)
O N C O L O G Y
(3.000,00€)